Baltimore, Maryland’s health department and a national advocacy group urged the Trump administration to invoke government authority to slash naloxone prices and increase access to the opioid overdo

Baltimore health officials are urging the Trump administration to use a law, which was last considered by the Bush administration during the 2001 anthrax scare , to cut the price of the opioid-over

The Baltimore City Health Department is looking to the Trump administration to expand access to the overdose reversal drug naloxone. It’s not the supply but the cost of the drug that jurisdictions like Baltimore are struggling with.

Watch the full video here.

The Trump administration should invoke government authority to slash prices of a life-saving overdose drug or provide funding to expand access amid the coast-to-coast opioid epidemic, Baltimore’s health department and a national advocacy group said Thursday.

Read the entire story.

Baltimore is making a first-of-its-kind request that the Trump administration use its existing authority to lower the cost of opioid overdose reversal drug naloxone in order to provide it to health care workers and law enforcement.

Read the entire story.

The Baltimore health department and a consumer advocacy group are urging the Trump administration to sidestep patents on a pair of opioid overdose antidotes in order to combat the opioid crisis.

Read the entire story.

The Trump administration should fight the opioid epidemic with a novel weapon, say the city of Baltimore and a consumer advocacy group: overriding patents on the widely-used overdose antidote naloxone.

Read the entire story.

Putting drug prices front and center at the Food and Drug Law Institute's (FDLI) annual conference Thursday, FDA Commissioner Scott Gottlieb took on some of the current rules and restrictions that prevent true market-based pricing and competition.

As Gottlieb was speaking at FDLI, the government watchdog group Public Citizen and the Baltimore City Health Department were calling on the Trump administration to address the high price of specific drugs used to reverse life-threatening opioid overdoses. The groups urged the government to use its march-in rights to enable generic competition for Kaleo Inc.'s naloxone auto-injector Evzio and Adapt Pharma Ltd.'s naloxone nasal spray Narcan.

Read the entire story.

In 2016, more than 20,000 Americans died after overdosing on the synthetic opioid fentanyl.

President Trump declared the opioid epidemic a national emergency and, you know, pretty much called it a day. 

Well today, activists and health officials sent a potential solution (or at least a way to help prevent overdose-related deaths) to presidential counselor Kellyanne Conway, who was put in charge of handling the public health crisis.

Read the entire story.

The Trump administration should invoke government authority to slash prices of a life-saving overdose drug or provide funding to expand access amid the coast-to-coast opioid epidemic, Baltimore's health department and a national advocacy group said Thursday. 

"What's short is our willpower to do something about it," said Baltimore Health Commissioner Dr. Leana Wen, who issued an innovative blanket prescription for naloxone in 2015.

Read the entire story.